- - The subject has read, signed, and dated an informed consent form (ICF) prior to any study
procedures being performed.
Patients with histologically confirmed multifocal and/or
metastatic neural crest tumor.
Subject should have a routine clinical 131I-MIBG scintigraphy (planar + SPECT/CT) performed
within 6 months prior to the inclusion visit or scheduled within 3 months after the
The subject is male or is a nonpregnant, nonlactating female who is either surgically
sterile or is post-menopausal. The subject is able and willing to comply with all study
procedures as described in the protocol.
- - Patients are potentially pregnant (serum and urinary hCG test will be performed in women
where pregnancy is not excluded) or is breast-feeding.
Patients undergo surgery between the selection and inclusion visit. Patients who are
pregnant, may possibly be pregnant, or wish (including their partners) to become pregnant
during the study period, or are lactating. Patients who are not suitable to participate in
the trial according to researchers.